[Chemotaxis of human polymorphonuclear cells in vitro. Study of inflammatory rheumatic diseases].
Sixty-eight determinations of leukocyte chemotaxis were performed in 42 patients suffering from systemic lupus erythematodes (17 cases), rheumatoid arthritis (15 cases) and scleroderma (10 cases). In contrast to the results of others, this study showed a deficiency in only 15 of 42 cases (35.7%). Impairment of chemotaxis was always transitory and demonstrable only during acute phases of disease. Intrinsic deficiency of PMN leukocytes as well as deficiency of plasma factors were related to the clinical and biological course of the disease and to the treatment.
D000974:Antibodies, Antinuclear / Q000032:analysis; D001172:Arthritis, Rheumatoid / Q000276:immunology*; D002633:Chemotaxis; D006098:Granulocytes / Q000276:immunology; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000276:immunology*; D012217:Rheumatoid Factor / Q000032:analysis; D012595:Scleroderma, Systemic; D005719:gamma-Globulins
D000974:Antibodies, Antinuclear; D005719:gamma-Globulins; D012217:Rheumatoid Factor
Chimiotactisme des polynucléaires humains in vitro. Etude dans les maladies rhumatismales inflammatoires